CSIMarket Company Name, Ticker, Competitors, else..
 
Peak Bio Inc   (NONE: PKBO)
 

Peak Bio Inc's Suppliers Performance

PKBO's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
PKBO Costs vs Sales of Suppliers Growth

• More on PKBO Suppliers






Peak Bio Inc's Comment on Supply Chain


The company sources raw materials and finished products directly from Bayer in Germany, which provides advanced CMC technology. Finished product manufacturing technology has been transferred to Catalent in the United States for clinical and commercial supply. The drug substance for PHP-303 is produced by Proton Pharma Solutions Ltd., while finished drug production is handled by Sherpa Clinical Packaging QC. The company does not own manufacturing facilities and operates through manufacturing agreements with various suppliers, including Bayer for clinical trial materials. It has not yet contracted for commercial supply manufacturing to maintain strategic flexibility for future partnerships.

Peak Bio Inc's Comment on Supply Chain


The company sources raw materials and finished products directly from Bayer in Germany, which provides advanced CMC technology. Finished product manufacturing technology has been transferred to Catalent in the United States for clinical and commercial supply. The drug substance for PHP-303 is produced by Proton Pharma Solutions Ltd., while finished drug production is handled by Sherpa Clinical Packaging QC. The company does not own manufacturing facilities and operates through manufacturing agreements with various suppliers, including Bayer for clinical trial materials. It has not yet contracted for commercial supply manufacturing to maintain strategic flexibility for future partnerships.







PKBO's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Peak Bio Inc 1.42 0.00 -3.32 -
SUBTOTAL 0.00 0.00 0.00 -


Sources: Peak Bio Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Peak Bio Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.